Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Pre-clinical and clinical development of the first placental malaria vaccine

Publikation: Bidrag til tidsskriftReviewForskningpeer review

  1. A vaccine targeted specifically to prevent cerebral malaria - is there hope?

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. The GMZ2 malaria vaccine: from concept to efficacy in humans

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Towards clinical development of a Pfs48/45-based transmission blocking malaria vaccine

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  4. The case for PfEMP1-based vaccines to protect pregnant women against Plasmodium falciparum malaria

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. A simple method for detecting oncofetal chondroitin sulfate glycosaminoglycans in bladder cancer urine

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Dynamics of PfEMP1 Antibody Profile From Birth to 12 Months of Age in Beninese Infants

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

INTRODUCTION: Malaria during pregnancy is a massive health problem in endemic areas. Placental malaria infections caused by Plasmodium falciparum are responsible for up to one million babies being born with a low birth weight every year. Significant efforts have been invested into preventing the condition. Areas covered: Pub Med was searched using the broad terms 'malaria parasite placenta' to identify studies of interactions between parasite and host, 'prevention of placental malaria' to identify current strategies to prevent placental malaria, and 'placental malaria vaccine' to identify pre-clinical vaccine development. However, all papers from these searches were not systematically included. Expert commentary: The first phase I clinical trials of vaccines are well underway. Trials testing efficacy are more complicated to carry out as only women that are exposed to parasites during pregnancy will contribute to endpoint measurements, further it may require extensive follow-up to establish protection. Future second generation vaccines may overcome the inherent challenges in making an effective placental malaria vaccine.

OriginalsprogEngelsk
TidsskriftExpert Review of Vaccines
Vol/bind16
Udgave nummer6
Sider (fra-til)613-624
Antal sider12
ISSN1476-0584
DOI
StatusUdgivet - jun. 2017

ID: 52820935